The Qatari National Center for Cancer Care and Research (NCCCR) genetic screening program uncovered 90 VUS in 78 patients with breast cancer; 29 patients with 36 BRCA1 VUS and 49 patients with 54 BRCA2 VUS. Here, BRCA2 is linked to breast carcinoma.